Latest Social Responsibility News

Codrus Minerals Limited posted a $1.41 million loss for FY26 as it confirmed gold and molybdenum mineralisation at Bull Run, rationalised its portfolio, and secured a binding acquisition of EdgeMet with a $2.5 million capital raise underway.

Comvita Limited has swung back to profitability in FY26, reporting $7.7 million net profit after a $40.5 million capital raise that brought Southeast Asian consumer giant F&N Ventures on board with a near 20% stake.

ImpediMed reported a 15% revenue increase to $14.6 million in FY26, broadened reimbursement coverage for its SOZO platform to 95% of the US population, and launched new applications in heart health and weight management.

Redox Limited posted a strong FY26 with record revenue of $1.33 billion, a 19.2% jump in statutory net profit, and a 4% dividend increase, while announcing a board leadership transition.

Acrux Limited reported a 46% revenue increase to $6.6 million in FY26, driven by US generic product royalties and licensing milestones, while narrowing its net loss by 90%. The company is pivoting towards developing a female testosterone therapy with encouraging Phase II data and active regulatory engagement.

Cedar Woods Properties delivered a record $65.6 million net profit after tax in FY26, up 36%, supported by strong presales and disciplined capital management, while targeting 15% NPAT growth in FY27.

Capral Limited posted a solid first half for 2026 with revenue rising 14% on higher aluminium prices and volume growth, while earnings remained steady despite cost pressures and subdued residential demand.

IPH Limited reported a 16.9% jump in net profit to $80.4 million for FY26, driven by strong Canadian growth and operational discipline, alongside a new CEO appointment and its inaugural sustainability report.

Pioneer Credit (ASX:PNC) has delivered a standout FY26 with a 245% surge in net profit after tax to $23.1 million, driven by disciplined debt portfolio investments and refinancing gains. The company sets ambitious targets for FY27-FY29, including a $35 million NPAT goal.

BHP Group Limited’s 2026 US Annual Report (Form 20-F) filed with the SEC details robust production across key assets, disciplined capital allocation, and advances in sustainability and leadership transition.

AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.

WA1 Resources has significantly increased the indicated resource at its Luni Niobium Project to 93 Mt at 1.32% Nb2O5, backed by A$131 million in cash and progressing key development workstreams including permitting and metallurgical testwork.